Detalhe da pesquisa
1.
Targeted Enhancer Activation by a Subunit of the Integrator Complex.
Mol Cell
; 71(1): 103-116.e7, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30008316
2.
Delayed Accumulation of H3K27me3 on Nascent DNA Is Essential for Recruitment of Transcription Factors at Early Stages of Stem Cell Differentiation.
Mol Cell
; 66(2): 247-257.e5, 2017 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28410996
3.
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs.
Blood
; 135(18): 1560-1573, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040545
4.
Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
Haematologica
; 104(1): 82-92, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076175
5.
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Nat Genet
; 30(1): 48-58, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11753385
6.
A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.
Leuk Res
; 129: 107075, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079999
7.
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
J Cell Biochem
; 113(5): 1704-13, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212957
8.
BCR/ABL activates mdm2 mRNA translation via the La antigen.
Cancer Cell
; 3(2): 145-60, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12620409
9.
Regulation of microRNA-145 by growth arrest and differentiation.
Exp Cell Res
; 317(4): 488-95, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21111732
10.
Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression.
Cancer Res
; 82(3): 458-471, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903608
11.
Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.
J Biol Chem
; 285(38): 29434-45, 2010 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-20622260
12.
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain.
J Biol Chem
; 285(40): 30837-50, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20659895
13.
Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Genes (Basel)
; 12(9)2021 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34573335
14.
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders.
Nat Commun
; 12(1): 6469, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753942
15.
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.
Blood
; 111(9): 4771-9, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18227349
16.
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
Blood
; 112(5): 1942-50, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18550858
17.
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.
Blood Cancer Discov
; 1(1): 48-67, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974613
18.
Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility.
Mol Cancer
; 8: 58, 2009 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19646290
19.
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model.
Int J Cancer
; 125(11): 2547-55, 2009 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19623650
20.
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models.
Clin Cancer Res
; 14(14): 4622-30, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18628477